Sana Biotechnology, Inc. (SANA)
NASDAQ: SANA · Real-Time Price · USD
4.580
-0.090 (-1.93%)
At close: Jan 16, 2026, 4:00 PM EST
4.600
+0.020 (0.44%)
After-hours: Jan 16, 2026, 7:55 PM EST
Sana Biotechnology Market Cap
Sana Biotechnology has a market cap or net worth of $1.22 billion as of January 16, 2026. Its market cap has increased by 235.22% in one year.
Market Cap
1.22B
Enterprise Value
1.16B
1-Year Change
235.22%
Ranking
Category
Stock Price
$4.58
Market Cap Chart
Since the IPO on February 4, 2021, Sana Biotechnology's market cap has decreased from $1.33B to $1.22B, a decrease of -7.93%. That is a compound annual growth rate of -1.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 1.22B | 12.53% |
| Dec 31, 2025 | 1.08B | 197.89% |
| Dec 31, 2024 | 363.93M | -54.75% |
| Dec 29, 2023 | 804.30M | 7.21% |
| Dec 30, 2022 | 750.19M | -73.52% |
| Dec 31, 2021 | 2.83B | 113.84% |
| Feb 4, 2021 | 1.33B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 924.04B |
| Johnson & Johnson | 528.05B |
| AbbVie | 384.80B |
| UnitedHealth Group | 306.78B |
| AstraZeneca | 291.28B |
| Novartis AG | 278.73B |
| Merck & Co. | 276.75B |
| Novo Nordisk | 252.12B |